Trials / Completed
CompletedNCT00440661
Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis
Exploratory Study of Some Synovial Fluid Inflammation Mediatorsunder Diacerhein in Knee Osteoarthritis Patients. Phase IV Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Laboratoires NEGMA · Industry
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Some inflammation mediators, notably IL-1, are implied in the joint degeneration phenomena of osteoarthritis. The aim of this study is to confirm in vivo the favourable effect of diacerhein on IL-1 and also to appreciate its effect on other synovial inflammation mediators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diacerhein |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2007-02-27
- Last updated
- 2010-03-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00440661. Inclusion in this directory is not an endorsement.